Fosun to buy $1.1bn stake in India’s Gland

Largest Indian corporate takeover by a Chinese company

GSK to invest £275m in UK capacity

Production boost for sites in Durham, Hertfordshire and Angus

Call for tests after prostate cancer rise

Increase in US may help end opposition to screening

T cell attacking cancer cell. 3D computer illustration of a T lymphocyte white blood cell (white) destroying a cancerous cell (purple). T lymphocytes, or T cells, are a type of white blood cell and a component of the body's immune system. They recognise a specific site on the surface of a pathogen or foreign object (antigen), bind to it, and produce antibodies or cells to eliminate it.
©Science Photo Library

Gene therapy: A controversial cure

Recent deaths raise fears that a treatment for blood cancers is being brought to market too quickly

Rivals for ‘off-the-shelf’ cancer remedy

Companies are developing products that modify cells taken from the patient’s own blood

UK-exposed stocks sink on slowdown fears

But FTSE reaches highest in almost a year on overseas-oriented equities

Roche warns of Brexit impact on UK research

Swiss group calls for new rules on innovative treatments

The limits of UK industrial strategy

May should beware the unintended consequences of state intervention, writes Geoffrey Owen

NHS head calls for pledge on EU staff

Government needs extra £500m a year to replace research funding

Novartis braced for US pricing shake-up

Swiss group warns of fallout from presidential election

Celgene in partnership to fight cancer

Biotech signs deal worth up to $2.6bn with start-up

Aids fight endangered by complacency

Global total of 36m people living with HIV is highest ever

Teva finalises bond sale of $15bn

Debt offering proceeds will fund Allergan drug unit purchase

Arm deal puts focus on UK industrial strategy

Theresa May promised more scrutiny of foreign takeovers

Sardinian genetic data sought for biobank

DNA gathered from region boasting wealth of centenarians

Former Valeant chief sells $100m of shares

Drugmaker insists sale is ‘not a reflection’ on its viability

Biosimilars set to rival two blockbusters

Makers of medicines with $22bn sales a year expected to fight hard to delay rivals

Shire boosted by FDA approval of eye drug

Analysts expect global annual sales of Xiidra to reach $2.5bn by 2030

Swiss tap anti-ageing effect of pomegranates

Research shows ‘powerful’ effect combating some effects of old age

Cancer drug trial deaths hit biotech shares

Setback for Juno Therapeutics’ revolutionary treatment

EDITOR’S CHOICE

Special report

insulin vials ©Jacob Ehrbahn Combating Diabetes

Special report

An elderly man uses a magnifier to see the descriptions on a pack of medicine at a pharmacy in Dandong, Liaoning province March 30, 2011 ©Jacky Chen/Reuter Health: Emerging Markets

COMPANIES NEWS ON TWITTER

More FT Twitter accounts
SHARE THIS QUOTE